Kaushik J Dave - Net Worth and Insider Trading

Kaushik J Dave Net Worth

The estimated net worth of Kaushik J Dave is at least $2 Million dollars as of 2024-04-19. Kaushik J Dave is the Executive Vice President of Antares Pharma Inc and owns about 265,028 shares of Antares Pharma Inc (ATRS) stock worth over $1 Million. Kaushik J Dave is also the CEO and Interim CFO of Actinium Pharmaceuticals Inc and owns about 2,950 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $19,795. Details can be seen in Kaushik J Dave's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kaushik J Dave has not made any transactions after 2016-04-14 and currently still holds the listed stock(s).

Transaction Summary of Kaushik J Dave

To

Kaushik J Dave Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kaushik J Dave owns 2 companies in total, including Actinium Pharmaceuticals Inc (ATNM) , and Antares Pharma Inc (ATRS) .

Click here to see the complete history of Kaushik J Dave’s form 4 insider trades.

Insider Ownership Summary of Kaushik J Dave

Ticker Comapny Transaction Date Type of Owner
ATNM Actinium Pharmaceuticals Inc 2016-04-14 director & President and CEO
ATRS Antares Pharma Inc 2013-06-03 Executive Vice President

Kaushik J Dave Latest Holdings Summary

Kaushik J Dave currently owns a total of 2 stocks. Among these stocks, Kaushik J Dave owns 265,028 shares of Antares Pharma Inc (ATRS) as of June 3, 2013, with a value of $1 Million and a weighting of 98.68%. Kaushik J Dave also owns 2,950 shares of Actinium Pharmaceuticals Inc (ATNM) as of April 14, 2016, with a value of $19,795 and a weighting of 1.32%.

Latest Holdings of Kaushik J Dave

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRS Antares Pharma Inc 2013-06-03 265,028 5.59 1,481,507
ATNM Actinium Pharmaceuticals Inc 2016-04-14 2,950 6.71 19,795

Holding Weightings of Kaushik J Dave


Kaushik J Dave Form 4 Trading Tracker

According to the SEC Form 4 filings, Kaushik J Dave has made a total of 0 transactions in Antares Pharma Inc (ATRS) over the past 5 years. The most-recent trade in Antares Pharma Inc is the sale of 48,000 shares on June 3, 2013, which brought Kaushik J Dave around $192,480.

According to the SEC Form 4 filings, Kaushik J Dave has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 333 shares on April 14, 2016, which cost Kaushik J Dave around $20,200.

Insider Trading History of Kaushik J Dave

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kaushik J Dave Trading Performance

GuruFocus tracks the stock performance after each of Kaushik J Dave's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kaushik J Dave is -15.42%. GuruFocus also compares Kaushik J Dave's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kaushik J Dave within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kaushik J Dave's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kaushik J Dave

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.95 -15.42 -41.79 -26.87 -56.86 -35.53
Relative Return to S&P 500(%) -9.21 -19.31 -44.2 -38.69 -69.81 -47.31

Kaushik J Dave Ownership Network

Ownership Network List of Kaushik J Dave

No Data

Ownership Network Relation of Kaushik J Dave


Kaushik J Dave Owned Company Details

What does Actinium Pharmaceuticals Inc do?

Who are the key executives at Actinium Pharmaceuticals Inc?

Kaushik J Dave is the director & President and CEO of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .

Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Actinium Pharmaceuticals Inc Insider Transactions

No Available Data

Kaushik J Dave Mailing Address

Above is the net worth, insider trading, and ownership report for Kaushik J Dave. You might contact Kaushik J Dave via mailing address: 4 Water Street, Edison Nj 08820.

Discussions on Kaushik J Dave

No discussions yet.